New drug combo trial aims to boost fight against Virus-Linked cancer
NCT ID NCT07348575
Summary
This study is testing if adding a drug called decitabine to the standard chemotherapy regimen (R-CHOP) works better for treating a specific type of aggressive lymphoma that is linked to the Epstein-Barr virus (EBV). It will involve 80 adults who are newly diagnosed and have not yet received treatment. The main goal is to see if the new combination helps keep the cancer from coming back for a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, LARGE-CELL, DIFFUSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.